U.S. Retail Distributors Stock News

Urban Outfitters (URBN) is back in focus after reporting fourth quarter and full year results, with higher sales in both periods, a mixed picture on net income, and a completed multi year share repurchase program. See our latest analysis for Urban Outfitters. The latest earnings release and completed buyback come after a weaker 30-day share price return of a 7.85% decline and a 90-day share price return of an 11.65% decline. However, the 1-year total shareholder return of 16.67% and 3-year...

Super Group (SGHC) stock is drawing fresh attention after the company reported strong adjusted EBITDA growth and margin expansion in its latest earnings report, along with higher 2026 revenue guidance and a richer dividend program. See our latest analysis for Super Group (SGHC). The latest earnings, higher 2026 revenue guidance and the richer dividend program appear to be supporting renewed momentum, with the 30 day share price return of 23.35% and a 1 year total shareholder return of 66.64%...

In late February 2026, Day One Biopharmaceuticals reported fourth-quarter 2025 revenue of US$53.7 million with a US$21.3 million net loss, and the European regulator’s committee issued a positive opinion supporting conditional marketing authorization of OJEMDA for relapsed or refractory BRAF‑altered pediatric low‑grade glioma. This combination of improving quarterly losses and progress toward conditional European approval for OJEMDA highlights both growing commercial traction and expanding...

In recent weeks, Capital One reported very large year-on-year revenue growth that beat analyst expectations, but missed earnings and net interest margin estimates, while facing a new securities-fraud investigation and ongoing integration of Discover and the planned Brex acquisition. These mixed results, combined with regulatory concerns such as potential interest rate caps and insider share sales under a trading plan, highlight how execution, legal risk, and policy shifts could influence...

HCA Healthcare, NYSE:HCA, is preparing for a financial impact linked to expected declines in Affordable Care Act insurance enrollments. The company is adjusting operations to this shift while pursuing AI integration, new emergency care centers, and leadership changes. These moves come as investors weigh the earnings impact projected for 2026 against the company’s longer term strategic initiatives. HCA Healthcare enters this period of change with its shares at $544.41, after a 71.6% return...

In February 2026, Texas Capital Bancshares completed a US$400,000,000 fixed-to-floating rate senior unsecured note offering due 2032, while director Robert W. Stallings bought 40,000 Series B preferred depositary shares and the bank reaffirmed a cash dividend on those shares. Institutional investors such as JPMorgan Chase and Quantbot Technologies expanded their positions as Texas Capital also earned a Best Bank recommendation for middle market clients. We’ll now examine how this combination...

TG Therapeutics and Precision BioSciences reported a new clinical milestone for azercabtagene zapreleucel in progressive multiple sclerosis. The milestone is tied to an exclusive worldwide license for autoimmune diseases between the two companies. The progress with azer cel adds a new autoimmune program alongside TG Therapeutics' existing BRIUMVI franchise. TG Therapeutics, trading on NasdaqCM:TGTX, is drawing fresh attention as it builds out its autoimmune pipeline beyond BRIUMVI. The...

Cigna Group (NYSE:CI) announced a CEO succession, with longtime chief executive David M. Cordani set to retire. Brian Evanko, currently a senior leader within the company, will assume the CEO role. The transition marks a significant leadership change at the top of the health services provider. Cigna Group operates as a global health services company, with a focus on medical benefits, pharmacy benefits, and related services for employers, governments, and individuals. Leadership shifts at a...

Amgen (NasdaqGS:AMGN) and Kyowa Kirin have decided to discontinue clinical development of rocatinlimab. The decision follows emerging safety concerns identified during ongoing clinical trials. All active studies of rocatinlimab are being halted, affecting programs in dermatology and immunology. For you as an investor, this matters because rocatinlimab had been part of Amgen's push into immunology and dermatology, areas that attract significant R&D interest across large biopharma companies...

What investors can see in Exact Sciences today Exact Sciences (EXAS) continues to attract attention as a cancer diagnostics business with US$3,246.99m in annual revenue, a reported net loss of US$207.949m, and a recent share price around US$103.50. See our latest analysis for Exact Sciences. At around US$103.50, Exact Sciences has seen relatively steady short term share price moves, while the 1 year total shareholder return of 117.30% contrasts with a 5 year total shareholder return decline...

Colgate-Palmolive stock snapshot and recent performance Colgate-Palmolive (CL) has drawn investor attention recently, with the share price at $95.28 and returns that include a 3.7% gain over the past month and 22.8% over the past 3 months. For a global consumer products group with two main segments (Oral, Personal and Home Care, and Pet Nutrition), these figures give you a reference point for how the stock has behaved before you look more closely at fundamentals. See our latest analysis for...

If you are wondering whether Compañía de Minas BuenaventuraA’s share price still reflects its underlying worth, starting with a clear look at valuation can help you frame that question properly. The stock recently closed at US$39.34, with returns of a 1.7% decline over 7 days, 15.5% over 30 days, 37.6% year to date, 196.6% over 1 year and 408.4% over 3 years, which can change how investors think about both upside and risk. Recent news coverage around Compañía de Minas BuenaventuraA has...

In February 2026, Procore Technologies and United Rentals announced a new partnership and telematics integration that lets shared customers feed United Rentals’ rental equipment data directly into Procore’s Resource Management platform to improve visibility and simplify equipment management across jobsites. This integration creates a unified view of owned and rented equipment alongside labor and materials, enabling AI-driven recommendations that can help contractors improve productivity,...

If you are wondering whether PDD Holdings is offering good value at its current price, you are not alone. This article is built to help you make sense of what the market might be pricing in. The stock recently closed at US$101.19, with returns of a 5.3% decline over 7 days, a 2.2% decline over 30 days, a 12.6% decline year to date, and a 15.8% decline over 1 year. The 3 year and 5 year returns sit at an 8.8% decline and a 31.7% decline respectively. Recent coverage has focused on PDD...

If you are wondering whether Rivian Automotive's share price matches what you are actually getting for your money, this article will walk through how its current market value stacks up against a few different valuation checks. Rivian's stock most recently closed at US$14.92, with returns of 3.3% over the last 30 days, a 30.6% gain over the past year, and declines of 2.2% over 7 days and 23.1% year to date. Recent headlines around Rivian have focused on its position in the electric vehicle...

Why Firefly Aerospace is on investors’ radar today Firefly Aerospace (FLY) has drawn investor attention after recent share price swings, with the stock up about 2.6% over the past day and roughly 5.2% over the past week. See our latest analysis for Firefly Aerospace. The recent 1-day share price return of 2.6% and 7-day share price return of 5.2% come after a weaker spell, with the 30-day share price return at a 6.4% decline and the year to date share price return at a 9.9% decline. This...

Why AI-driven trading signals are suddenly focusing on Seaboard AI-driven trading systems have recently flagged Seaboard (SEB) for what they view as favorable risk reward setups across multiple timeframes, drawing fresh institutional attention to a stock many retail investors rarely watch. See our latest analysis for Seaboard. While Seaboard’s share price has eased in the last month, with a 1 month share price return decline of 2.33%, the 90 day share price return of 14.20% alongside a 1 year...

Why Bitdeer’s latest capital raise matters for shareholders Bitdeer Technologies Group (BTDR) has just raised fresh capital through a US$43.7 million follow on equity offering, shortly after completing a US$325 million convertible bond issue. This puts its funding decisions in focus for current and prospective shareholders. These back to back transactions give Bitdeer more financial resources to work with. However, they also introduce questions about dilution, future interest costs, and how...

Why Brookdale’s latest earnings are moving the stock Brookdale Senior Living (BKD) is back in focus after its Q4 earnings report, where revenue declined year on year and came in 1.7% below analyst expectations, pressuring the share price. At the same time, full year EBITDA guidance matched analyst estimates, and management emphasized Brookdale’s positioning to serve increasing senior housing demand in what it describes as a period of limited new supply. See our latest analysis for Brookdale...

Why Ameren’s new bond issuance matters for stock investors Ameren (AEE) is back in the debt markets, with Ameren Missouri issuing new first mortgage bonds and fixed rate notes to refinance short term borrowings and fund ongoing grid investments. See our latest analysis for Ameren. Against this refinancing backdrop, Ameren’s share price has climbed to US$113.33, with a 10.7% 1 month share price return and 12.4% year to date. Meanwhile, 1 year total shareholder return sits at 18.2% and 5 year...

Targa Resources (TRGP) just completed a US$1.5b senior notes offering, pairing this new debt financing with record 2025 adjusted EBITDA, higher planned 2026 capital spending, and a proposed 25% dividend increase. See our latest analysis for Targa Resources. That refinancing move comes on top of record 2025 profits, fresh Permian growth projects and a planned 25% dividend uplift. It also lands as momentum in the shares has been strong, with a 30 day share price return of 22.34% and a very...

In February 2026, The Carlyle Group announced a Board-approved share repurchase program of up to US$2.00 billion of its common stock as part of a wider turnaround under CEO Harvey Schwartz. This buyback, alongside an ambition to raise US$200.00 billion of new capital and increase fee-related earnings, highlights management’s confidence in the firm’s reshaped business model. We’ll now examine how Carlyle’s US$2.00 billion share repurchase authorization could reshape its investment narrative...

Recent performance and business scale Without a single clear news headline driving it today, Monolithic Power Systems (MPWR) still gives you plenty to work with, thanks to a detailed snapshot of recent returns and fundamentals. The stock’s recent moves have been mixed, with a 2.3% gain over the past day, a 10.8% decline over the past week, and a 6.3% decline over the past month, set against a 15.4% gain over the past 3 months. Over longer periods the total return figures are 17.4% year to...

Why recent insider sales and business shifts are putting Oceaneering International (OII) in focus Recent insider share sales at Oceaneering International (OII), alongside its push toward robotics, digital solutions, and government contracts in defense, aerospace, and renewables, have put the stock firmly on many investors’ watchlists. See our latest analysis for Oceaneering International. At a share price of $35.14, Oceaneering’s 30 day share price return of 15.1% and year to date share price...